Hypermobility, Hypermobility Spectrum Disoders and Hypermobile EDS Podcast Por  arte de portada

Hypermobility, Hypermobility Spectrum Disoders and Hypermobile EDS

Hypermobility, Hypermobility Spectrum Disoders and Hypermobile EDS

Escúchala gratis

Ver detalles del espectáculo

Welcome Back Rheumatology Fans,

Many of you will remember Mike from “Rheum Mates” which was a podcast series that we did a few years back. It is never boring chatting with him and so we discussed his PhD of all things which is on the sometimes spicy topic Hypermobility!

2017 hEDS Criteria: https://onlinelibrary.wiley.com/doi/10.1002/ajmg.c.31552

For case studies, webinars and a whole lot more - upgrade to the paid substack or enroll in my online course HERE

Below is an AI Summary Of The Podcast

Mikes PhD Focus & Research Direction

* Original Aim: Investigate evidence for conservative (non-surgical, non-pharmacological) management of HSD/hEDS in adults.

* Shifted Focus: Now looking at pediatric cohorts due to a lack of robust adult RCTs.

* Adult studies are often low-quality, opinion-based, or use flawed inclusion criteria (e.g. only Beighton score).

* Pediatric studies have more rigorous RCTs with better sample sizes and clearer outcomes.

📚 Key Learnings from the Literature

* Hypermobility ≠ HSD or hEDS:Many people are hypermobile (e.g., "double-jointed") but are asymptomatic and don’t meet diagnostic criteria.

* Beighton Score Alone Is Inadequate:It doesn’t account for widespread pain or systemic symptoms—should not be used in isolation to diagnose HSD/hEDS.

* Proper Criteria Needed:Diagnosis should be based on the Brighton criteria or 2017 hEDS criteria, not just joint flexibility.

👶 Pediatrics & Early Diagnosis

* Delay in Diagnosis Is Common:Many are misdiagnosed or ignored—sometimes taking up to 15 years to get a correct diagnosis.

* Symptoms Often Multi-Systemic:Includes joint pain, dislocations, stretchy skin, fatigue, GI issues, POTS, anxiety, etc.

* Early Diagnosis Matters:Leads to better patient outcomes, validation of their symptoms, and appropriate support.

🧠 Clinical Challenges

* Heterogeneity:Two people with hypermobility can present very differently—one may function as an elite athlete, the other may be disabled.

* Unclear Why Some Develop HSD/hEDS:Genetics don’t yet explain it fully. Severity of hypermobility does not predict chronic pain or dysfunction.

🏃 Management & Treatment

* Exercise & Education Are Key:Strong evidence shows structured exercise improves pain and function.

* Two RCTs (Kemp et al. & PACL) showed general exercise programs work just as well as targeted ones in children with hEDS.

* Surgery & Medication Less Effective:Lack of evidence supporting these as primary treatment options.

* Athletes May Self-Manage by Staying Active:Gymnasts and dancers often remain asymptomatic due to regular strength and mobility training.

Clinical Tips to Avoid Missing Diagnoses

* Distinguish Hypermobile Joints from HSD/hEDS:Most hypermobile individuals are healthy—don’t over-diagnose.

* Use Full Diagnostic Criteria:Don’t rely on the Baten score alone; use Brighton or 2017 hEDS criteria.

* Educate & Empower Patients:Reassure them that appropriate exercise and education can improve quality of life.

* Recognize Impact of Delay:Long-term mismanagement leads to worsening symptoms, mental health issues, and loss of function.



This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit rheumatologyphysio.substack.com/subscribe
Todavía no hay opiniones